Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Post by RazeKreationson Feb 02, 2021 7:33pm
187 Views
Post# 32453930

Not a flash in the pan

Not a flash in the panWhat is really going to propel value will be having the income raise EPS above 0. Currently at. -6 cents per share. If it gains ground towards the positive and that is going to happen soon then you will see Robert McWhirter and Eden Rahim as well as analysts come onboard promoting MBX. The report coming out next week will be very positive. That one will not have any vtm sales in it because it is for Oct 1 to Dec 31 2020 before vtm sales began. 2nd quarter results will be in middle of May which will have the first vtm sales included from Jan 1 to March 31 2021. Exciting times for sure. Best of all, this is a long term business with multiple products that are in demand now and growing in demand. Not a flash in the pan
<< Previous
Bullboard Posts
Next >>